Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nasopharyngeal Carcinoma × temoporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Head and Neck Neoplasms 2 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 47 Gemcitabine 24 toripalimab 17 Radiotherapy, Intensity-Modulated 17 Capecitabine 16 Fluorouracil 15 Docetaxel 14 camrelizumab 13 nimotuzumab 12 apatinib 9 Drug Therapy 9 Radiotherapy 8 sintilimab 7 Nivolumab 7 tislelizumab 6 spartalizumab 6 endostar protein 6 Specimen Handling 6 Magnetic Resonance Spectroscopy 6 Bevacizumab 6 pembrolizumab 5 nedaplatin 5 Radiation 5 Immune Checkpoint Inhibitors 5 Endostatins 5 Chemoradiotherapy 5 Cetuximab 5 S 1 (combination) 4 Paclitaxel 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡